← Eichor
Study identifier: NCT05500833 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Multidimensional Characterization of Dyspnea in Children

Condition: Dyspnea and Respiratory Insufficiency in Children  ·  Sponsor: Assistance Publique - Hôpitaux de Paris

PhaseN/A
Planned participants400
Who can joinAll sexes, 6 Years to 17 Years
Healthy volunteersNo

About this study

There is no specific tool existing to describe dyspnea in children in a multidimensional way. It has been shown in adult studies that multidimensional dyspnea evaluation scales are well correlated to quality of life and respiratory function impairments. The investigators hypothesis is that using multidimensional dyspnea evaluation scales could allow for a more systematic and precise evaluation of this symptom in children, thus improving management and follow-up of patients presenting with acute (asthma attack, infectious diseases) and chronic (cystic fibrosis, primary ciliary diskynesia, neuromuscular diseases) respiratory insufficiency.

This description comes directly from the study's public registry record.

Talk to the study team

Jessica TAYTARD, MD, PhD  ·  +33677855889  ·  jessica.taytard@aphp.fr

Capucine MORELOT-PANZINI, MD, PhD  ·  +331 42 16 77 71  ·  capucine.morelot@aphp.fr

Always discuss trial participation with your own doctor first.

Locations (1)

Service de pneumologie pédiatrique, Hôpital Armand TrousseauParis, FranceRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05500833